目的:为了研究小青龙加减联合右美沙芬片治疗慢性支气管炎的临床疗效,我们选取了2022年3月到6月的60名患者,按1到60号对患者进行排序,采用随机抽样法,偶数为研究组,奇数为对照组。研究组采用小青龙汤加减治疗,对照组采用右美沙芬片治疗...目的:为了研究小青龙加减联合右美沙芬片治疗慢性支气管炎的临床疗效,我们选取了2022年3月到6月的60名患者,按1到60号对患者进行排序,采用随机抽样法,偶数为研究组,奇数为对照组。研究组采用小青龙汤加减治疗,对照组采用右美沙芬片治疗。研究两组的治疗效果。结果发现:研究组治疗有效率为96.7%,对照组治疗有效率为90.0%,研究组显然高于对照组。两组对比差异有统计学意义(P Objective: To study the clinical efficacy of modified Xiaoqinglong decoction combined with dextromethorphan tablets in chronic bronchitis, we selected 60 patients from March to June 2022, ranked patients by 1 to 60, using random sampling method, even number for the study group and odd number for the control group. The study group was treated with modified Xiaoqinglong decoction, and the control group was treated with dextromethorphan tablets. To study the treatment effect in both groups. The results found that the effective rate of the study group was 96.7%, and the control group was 90.0%, and the study group was obviously higher than the control group. The difference between the two groups was statistically significant (P < 0.05). Before treatment, there was no significant difference in symptoms such as cough, expectoration, wheezing, fever, headache between the two groups. After treatment, the study group and the control group improved significantly, but the study group improved more significantly. The clinical symptoms disappeared early after treatment, and the difference compared with the control group was statistically significant (P < 0.05). Conclusion: Modified Xiaoqinglong decoction is highly effective in treating chronic bronchitis, and cough, expectoration, wheezing, fever and cold, headache and other symptoms disappear quickly, which is more effective than the control group, making it worthy of widespread promotion in clinical practice.展开更多
文摘目的:为了研究小青龙加减联合右美沙芬片治疗慢性支气管炎的临床疗效,我们选取了2022年3月到6月的60名患者,按1到60号对患者进行排序,采用随机抽样法,偶数为研究组,奇数为对照组。研究组采用小青龙汤加减治疗,对照组采用右美沙芬片治疗。研究两组的治疗效果。结果发现:研究组治疗有效率为96.7%,对照组治疗有效率为90.0%,研究组显然高于对照组。两组对比差异有统计学意义(P Objective: To study the clinical efficacy of modified Xiaoqinglong decoction combined with dextromethorphan tablets in chronic bronchitis, we selected 60 patients from March to June 2022, ranked patients by 1 to 60, using random sampling method, even number for the study group and odd number for the control group. The study group was treated with modified Xiaoqinglong decoction, and the control group was treated with dextromethorphan tablets. To study the treatment effect in both groups. The results found that the effective rate of the study group was 96.7%, and the control group was 90.0%, and the study group was obviously higher than the control group. The difference between the two groups was statistically significant (P < 0.05). Before treatment, there was no significant difference in symptoms such as cough, expectoration, wheezing, fever, headache between the two groups. After treatment, the study group and the control group improved significantly, but the study group improved more significantly. The clinical symptoms disappeared early after treatment, and the difference compared with the control group was statistically significant (P < 0.05). Conclusion: Modified Xiaoqinglong decoction is highly effective in treating chronic bronchitis, and cough, expectoration, wheezing, fever and cold, headache and other symptoms disappear quickly, which is more effective than the control group, making it worthy of widespread promotion in clinical practice.